Interactive Chart for Emergent BioSolutions Inc. (EBS), analyze all the data with a huge range of indicators.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial...

Get the latest Emergent Biosolutions Inc (EBS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

2025年3月1日 · The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts.

2025年3月3日 · The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts.

Emergent Biosolutions Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time EBS stock price.

Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest...

Emergent BioSolutions scored higher than 83% of companies evaluated by MarketBeat, and ranked 169th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Emergent BioSolutions has received a consensus rating of Buy.

Find the latest Emergent BioSolutions Inc. (EBS) stock quote, history, news and other vital information to help you with your stock trading and investing.

2025年1月16日 · Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results. Fourth Quarter 2024 Total Revenues of $194.7 million ; Full Year 2024 Total Revenues of $1.04 billion Fourth Quarter 2024 Net Loss of $31.3 million , decrease in Net Loss of 37% versus prior year Fourth Quarter 2024 Adjusted EBITDA of $21.0 million , increase of 518% versus prior year Full Year